ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark.

As costs of cancer care rise, there has been a shift to focus on value. Drug wastage affects costs to patients and health care systems without adding value. Historically, cost-effectiveness analyses ...

As experts in hematology, HORIBA Medical designs and manufactures a broad portfolio of systems capable of measuring a range of potential COVID-19 biomarkers, both at the point-of-care and in the ...

ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark.

Adjusting for Drug Wastage in Economic Evaluations of New Therapies for Hematologic Malignancies: A Systematic Review. JOP 12 , e369-e379 (2016). DOI: 10.1200/JOP.2015.005876 ...